Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Operating Activities
Net loss attributable to common stockholders	$ (52,501,824)	$ (22,191,140)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	1,678,730	96,681
Amortization and accretion of financing costs	4,194,971
Amortization of right-of-use asset	101,051	101,049
Impairment charge on held-for-sale assets	10,254,037
Stock-based compensation	14,566,318	9,757,395
Shares issued for professional services	(133)	43,895
Change in fair value of derivative liability	338,886
Changes in operating assets and liabilities:
Accounts receivable	(228,499)
Inventory	(29,116)	(125,204)
Grant receivables	128,935	(320,457)
Prepaid expenses and deposits	(551,420)	(887,403)
Accounts payable and accrued liabilities	5,311,833	157,204
Net cash used in operating activities	(16,736,231)	(13,367,980)
Investing Activities
Other acquisition deposits	(279,878)	(21,881,587)
Acquisition of property and equipment	(11,752,994)	(6,761,851)
Purchase of mining properties	(169,654)	(8,073,323)
Purchase of water rights/intangible assets	(766,693)
Net cash used in investing activities	(12,969,219)	(36,716,761)
Financing Activities
Proceeds from exercise of share purchase warrants	37,497
Principal paid on notes payable	(24,000,000)
Proceeds from notes payable, net of debt discount	20,289,104	6,000,000
Proceeds from issuance of common shares, net of issuance costs		13,857,351
Proceeds from share purchase agreements	38,060,486	3,558,373
Net cash provided by financing activities	34,387,087	23,415,724
Increase (decrease) in cash	4,681,637	(26,669,017)
Cash – beginning of period	2,320,149	28,989,166
Cash – end of period	$ 7,001,786	$ 2,320,149